Transition Therapeutics

Transition is a biopharmaceutical company that develops novel therapeutics for central nervous system and metabolic disease indications.

Business Model:

Revenue: $17.9M

Employees: 11-50

Detailed Transition Therapeutics Information

Transition Therapeutics was acquired by OPKO Health.
The acquisition happend on 2016-06-30.
Details of the transaction were not public

Acquirer

Geographic Data

Transition Therapeutics headquarters map

Address: 101 College Street

City: Toronto

State: ontario

Zip: M5G 1L7

Country: CA

Financial Info

Stage:

post ipo equity

Raised Last:

$31M

Raised Total:

$42M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Transition is a biopharmaceutical company that develops novel therapeutics for central nervous system and metabolic disease indications.

Contact Phone:
+14162607770

Contact Email:

Transition Therapeutics went public on 8/31/2007 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
8/31/2007

Ticker Symbol:
TTHI

Amount Raised:
$22M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research